KalVista Pharmaceuticals Inc. – Material Contracts Watch

from 10-KT 3 pages Third Amendment to Purchase and Sale Agreement

from 10-KT 15 pages Executive Employment Agreement

from 10-Q 3 pages Second Amendment to Purchase and Sale Agreement

from 10-Q 3 pages Amendment to Purchase and Sale Agreement

from 8-K 12 pages Indemnity Agreement

from 10-K 41 pages KalVista Pharmaceuticals, Inc. $100,000,000 Common Stock Sales Agreement

from 10-K 77 pages License, Supply, and Distribution Agreement Between Kaken Pharmaceutical Co., Ltd. and KalVista Pharmaceuticals, Ltd. Dated April 8, 2025

from 10-Q 38 pages Dated 4 November 2024 KalVista Pharmaceuticals Limited as Company and Dri Healthcare Acquisitions LP as Purchaser Debenture Creating Fixed and Floating Charges Slaughter and May One Bunhill Row London Ec1y 8yy Contents

from 10-Q 66 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and of the Type That the Registrant Treats as Private and Confidential. Purchase and Sale Agreement by and Among KalVista Pharmaceuticals Limited, Dri Healthcare Acquisitions LP And, Solely for the Purposes of the Guarantor Provisions, Kalvista Pharmaceuticals, Inc. Dated as of November 4, 2024

from 8-K 17 pages Amended and Restated Executive Employment Agreement

from 8-K 17 pages Amended and Restated Executive Employment Agreement

from 8-K 17 pages Executive Employment Agreement

from 10-Q 19 pages March 6, 2024 via E-Mail T. Andrew Crockett [***] Re: Terms of Separation Dear Andrew: This Letter Confirms the Agreement (This “Agreement”) Between You and KalVista Pharmaceuticals, Inc. (The “Company”) Concerning the Terms of Your Separation and Offers You the Separation Compensation We Discussed in Exchange for a General Release of Claims and Covenant Not to Sue. 1. Separation Date: March 6, 2024 Is Your Last Day of Employment With the Company (The “Separation Date”). 2. Resignation From Officer Positions and Board Membership: Effective as of the Separation Date, You Hereby Resign From All Officer Positions and All Positions on the Company’s Board of Directors (The “Board”) Without the Need of Acceptance or Any Further Action by the Company. 3

from 10-Q 61 pages Lease Agreement

from 10-K 20 pages Amended and Restated Executive Employment Agreement

from 8-K 16 pages Amended and Restated Executive Employment Agreement

from 8-K 11 pages Form of Subscription Agreement

from 10-K 70 pages 1.purpose. the Purpose of This Plan Is to Provide Incentives to Attract and Motivate Eligible Employees Whose Potential Contributions Are Important to the Success of the Company, and Any Parents, Subsidiaries and Affiliates That Exist Now or in the Future, by Offering Them an Opportunity to Participate in the Company’s Future Performance Through the Grant of Awards. Capitalized Terms Not Defined Elsewhere in the Text Are Defined in Section 22. 2. Shares Subject to the Plan

from 10-K 15 pages Executive Employment Agreement

from 10-Q 19 pages First Amendment of Lease